Home » FDA to Update Regulation on Combination Products
FDA to Update Regulation on Combination Products
November 15, 2006
The intercenter agreements (ICAs) governing how combination and single-entity products are assigned to FDA centers have become incomplete statements due to a slew of emerging products and the large volume of jurisdictional decisions the agency has made in recent years, the FDA said.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor